ArticleInternational urology and nephrology2026
Horseshoe kidney and polycystic horseshoe kidney: a forensic autopsy-based study in Portugal.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Horseshoe kidney (HSK) is the most common congenital renal fusion anomaly, while autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent inherited renal disorder. Their coexistence-polycystic horseshoe kidney (P-HSK)-is exceedingly rare. This retrospective forensic study assessed the prevalence of HSK and P-HSK in a consecutive autopsy series from the three regional delegations of the Portuguese National Institute of Legal Medicine and Forensic Sciences between 2017 and 2022. A total of 31,325 autopsy reports (22,854 males and 8,471 females) were reviewed. HSK was identified in 17 cases (0.054%; 95% CI: 0.032%-0.087%), including 3 cases (17.7%) of P-HSK (0.0096%; 95% CI: 0.0020%-0.0280%). None had been diagnosed in life, nor were other developmental anomalies present. The mean age of HSK cases was 55.3 ± 12.8 years. Causes of death did not significantly differ between individuals with or without HSK, and no deaths were attributable to HSK. Prevalence did not vary significantly by sex (p = 0.75) or nationality (p = 0.36). Among native Portuguese, HSK and P-HSK prevalence were 0.048% and 0.010%, respectively. The observed prevalence of P-HSK was significantly higher than expected under the assumption of independent occurrence. Regionally, HSK prevalence was higher in the North than in the Centre and South, although differences did not reach statistical significance (p = 0.083); notably, the North is also the region with the highest prevalence of ADPKD. This study provides population-specific data on asymptomatic HSK in Portugal and suggests a possible epidemiological association between HSK and ADPKD, warranting further investigation.
Indexed as
Identifiers
41484516What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.